World's Best Scientists 2026 revealed!
Kazuto Nishio

Kazuto Nishio

D-Index & Metrics

Medicine

D-Index
97
Citations
29220
World Ranking
9411
National Ranking
252

Kazuto Nishio publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Kazuto Nishio sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 841 publications — 89th percentile

89% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Kazuto Nishio D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Kazuto Nishio sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 97 D-Index — 55th percentile

55% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Kazuto Nishio is affiliated with Kindai University in Japan. Their research focuses primarily on medicine, with substantial contributions to biochemistry, genetics, and molecular biology. Within these broad fields, Nishio's work extensively covers oncology, pulmonary and respiratory medicine, cancer research, molecular biology, and pathology and forensic medicine.

The scientist has contributed significantly to topics related to lung cancer treatments and mutations, cancer genomics and diagnostics, cancer immunotherapy and biomarkers, colorectal cancer treatments and studies, lung cancer research studies, lung cancer diagnosis and treatment, and prostate cancer treatment and research.

Some of Nishio's recent papers include:

  • "Site-Specific and Targeted Therapy Based on Molecular Profiling by Next-Generation Sequencing for Cancer of Unknown Primary Site" (2020, JAMA Oncology)
  • "KRAS Inhibitor Resistance in MET -Amplified KRAS G12C Non-Small Cell Lung Cancer Induced By RAS- and Non-RAS-Mediated Cell Signaling Mechanisms" (2021, Clinical Cancer Research)
  • "Clinical Application of the FoundationOne CDx Assay to Therapeutic Decision-Making for Patients with Advanced Solid Tumors" (2020, The Oncologist)
  • "Clinical practice guidance for next-generation sequencing in cancer diagnosis and treatment (edition 2.1)" (2020, International Journal of Clinical Oncology)
  • "Immunological Microenvironment Predicts the Survival of the Patients with Hepatocellular Carcinoma Treated with Anti-PD-1 Antibody" (2021, Liver Cancer)

Nishio frequently collaborates with a group of co-authors, including Kazuko Sakai, Kazuhiko Nakagawa, Hidetoshi Hayashi, Marco A. De Velasco, and Hirotsugu Uemura.

The scientist's work is published regularly in several established venues. Frequent publication venues for Nishio include Cancer Research, Annals of Oncology, Journal of Clinical Oncology, JTO Clinical and Research Reports, and Cancer Science.

Best Publications

  • Novel Cisplatin-Incorporated Polymeric Micelles Can Eradicate Solid Tumors in Mice

    Nobuhiro Nishiyama;Souichiro Okazaki;Horacio Cabral;Masaki Miyamoto

  • Activation of ERBB2 Signaling Causes Resistance to the EGFR-Directed Therapeutic Antibody Cetuximab

    Kimio Yonesaka;Kreshnik Zejnullahu;Isamu Okamoto;Taroh Satoh

  • LUX-Lung 4: A Phase II Trial of Afatinib in Patients With Advanced Non–Small-Cell Lung Cancer Who Progressed During Prior Treatment With Erlotinib, Gefitinib, or Both

    Nobuyuki Katakami;Shinji Atagi;Koichi Goto;Toyoaki Hida

  • Detection of Epidermal Growth Factor Receptor Mutations in Serum as a Predictor of the Response to Gefitinib in Patients with Non–Small-Cell Lung Cancer

    Hideharu Kimura;Kazuo Kasahara;Makoto Kawaishi;Hideo Kunitoh

  • METALLOTHIONEIN CONTENT CORRELATES WITH THE SENSITIVITY OF HUMAN SMALL CELL LUNG CANCER CELL LINES TO CISPLATIN

    Kazuo Kasahara;Yasuhiro Fujiwara;Yasuhiro Fujiwara;Kazuto Nishio;Tohru Ohmori

  • Antibody-dependent cellular cytotoxicity of cetuximab against tumor cells with wild-type or mutant epidermal growth factor receptor.

    Hideharu Kimura;Kazuko Sakai;Tokuzo Arao;Tatsu Shimoyama

  • Epidermal Growth Factor Receptor Mutation Status in Circulating Free DNA in Serum: From IPASS, a Phase III Study of Gefitinib or Carboplatin/Paclitaxel in Non-small Cell Lung Cancer

    Koichi Goto;Yukito Ichinose;Yuichiro Ohe;Nobuyuki Yamamoto

  • Evaluation of epidermal growth factor receptor mutation status in serum DNA as a predictor of response to gefitinib (IRESSA)

    H Kimura;M Suminoe;K Kasahara;T Sone

  • Tumor immune microenvironment and nivolumab efficacy in EGFR mutation-positive non-small-cell lung cancer based on T790M status after disease progression during EGFR-TKI treatment.

    K. Haratani;H. Hayashi;T. Tanaka;H. Kaneda

  • Apoptosis of Lung Cancer Cells Caused by Some Anti-cancer Agents (MMC, CPT-11, ADM) is Inhibited by BCL-2

    Tohru Ohmori;Eckhard R. Podack;Kazuto Nishio;Minako Takahashi

  • FGFR2 gene amplification and clinicopathological features in gastric cancer

    K Matsumoto;T Arao;T Hamaguchi;Y Shimada

  • FOXQ1 is overexpressed in colorectal cancer and enhances tumorigenicity and tumor growth.

    Hiroyasu Kaneda;Tokuzo Arao;Kaoru Tanaka;Daisuke Tamura

  • Osteopontin overproduced by tumor cells acts as a potent angiogenic factor contributing to tumor growth.

    Michihiro Hirama;Fumiyuki Takahashi;Fumiyuki Takahashi;Kazuhisa Takahashi;Shigeru Akutagawa

  • Thymidylate Synthase as a Determinant of Pemetrexed Sensitivity in Non-Small Cell Lung Cancer

    K Takezawa;I Okamoto;W Okamoto;M Takeda

  • AZD2171 Shows Potent Antitumor Activity Against Gastric Cancer Over-Expressing Fibroblast Growth Factor Receptor 2/Keratinocyte Growth Factor Receptor

    Masayuki Takeda;Tokuzo Arao;Hideyuki Yokote;Teruo Komatsu

  • Phase I Dose-Escalation Study and Biomarker Analysis of E7080 in Patients with Advanced Solid Tumors

    Kazuhiko Yamada;Noboru Yamamoto;Yasuhide Yamada;Hiroshi Nokihara

  • FcγR2A and 3A polymorphisms predict clinical outcome of trastuzumab in both neoadjuvant and metastatic settings in patients with HER2-positive breast cancer

    K. Tamura;C. Shimizu;T. Hojo;S. Akashi-Tanaka

  • Synergism between Cisplatin and Topoisomerase I Inhibitors, NB-506 and SN-38, in Human Small Cell Lung Cancer Cells

    Minoru Fukuda;Kazuto Nishio;Fumihiko Kanzawa;Hayato Ogasawara

  • Alteration of caspase-3 (CPP32/Yama/apopain) in wild-type MCF-7, breast cancer cells.

    H Kurokawa;K Nishio;H Fukumoto;A Tomonari

  • Akt-dependent nuclear localization of Y-box-binding protein 1 in acquisition of malignant characteristics by human ovarian cancer cells

    Y Basaki;F Hosoi;F Hosoi;Y Oda;A Fotovati

Frequent Co-Authors

Kazuhiko Nakagawa
Kazuhiko Nakagawa Kindai University
Isamu Okamoto
Isamu Okamoto Kyushu University
Nagahiro Saijo
Nagahiro Saijo AstraZeneca (United Kingdom)
Tomohide Tamura
Tomohide Tamura St. Luke's International Hospital
Tetsuya Mitsudomi
Tetsuya Mitsudomi Kindai University
Yuichiro Ohe
Yuichiro Ohe National Cancer Centre
Narikazu Boku
Narikazu Boku St. Marianna University School of Medicine
Masahiro Fukuoka
Masahiro Fukuoka Kindai University
Masatoshi Kudo
Masatoshi Kudo Kindai University
Akihiko Ito
Akihiko Ito Kindai University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in healthcare careers beyond a traditional MD, there are a number of related online degrees and career pathways to consider. Online learning options can offer greater flexibility and affordability while still leading to rewarding jobs in medicine and healthcare.

Many choose to start with medical billing and coding classes online. These programs offer entry into the administrative side of healthcare and require less time and investment than a full degree.

For aspiring nurses, it’s important to ask how much does online nursing school cost before enrolling. Affordable nursing programs are available and can help you avoid excessive debt as you enter the profession.

Those wishing to advance their nursing credentials may look into cheapest nurse practitioner programs, which provide greater autonomy and earning potential. For those aiming even higher, cheapest dnp programs online can unlock advanced practice and leadership opportunities.

Exploring these online pathways can be a smart way to enter or progress in the medical and healthcare fields while managing costs.

Best Scientists Citing Kazuto Nishio

Trending Scientists

Recently Published Articles